Debevoise & Plimpton LLP is advising Johnson & Johnson Consumer Inc. on the deal
Johnson & Johnson Consumer Inc. announced today that it has entered into a definitive agreement to acquire Zarbee’s, Inc., a privately held company that is a leader in naturally-based healthcare products. The acquisition will include the full line of Zarbee’s Naturals™ products for children and adults. Financial terms of the transaction were not disclosed.
Zarbee’s Naturals™ was founded in 2008 by Dr. Zak Zarbock, a pediatrician who was inspired to create safe, wholesome and effective alternatives to traditional OTC medicines. His first product was a honey-based kids’ cough syrup made with vitamin C and zinc and free of alcohol, drugs, and artificial flavors. Over the last decade, Zarbee’s Naturals™ has grown into a broad-based health and wellness brand and has disrupted the cough, sleep, immune support and vitamin categories with its portfolio of family-friendly products.
The closing of the transaction is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions. The transaction is expected to close during the third quarter of 2018.
The Debevoise team is led by partners Jennifer L. Chu (Picture) and Kevin Rinker and includes partners Peter A. Furci, Meir D. Katz and Henry Lebowitz and associates Katherine M. Arango, Joseph M. Binder, Spencer K. Gilbert, Stephen J. Kozey and Milan Prodanovic.
Involved fees earner: Jennifer Chu – Debevoise & Plimpton; Kevin Rinker – Debevoise & Plimpton; Joe Binder – Debevoise & Plimpton; Spencer Gilbert – Debevoise & Plimpton; Stephen Kozey – Debevoise & Plimpton; Milan Prodanovic – Debevoise & Plimpton; Peter Furci – Debevoise & Plimpton; Katherine Arango – Debevoise & Plimpton; Meir Katz – Debevoise & Plimpton; Henry Lebowitz – Debevoise & Plimpton;
Law Firms: Debevoise & Plimpton;